The methylation levels of BOLA2B, FGF8, HSPA6, LYPD2 and SHE were low in normal cervix, low grade lesions and CIN3/CIS, but significantly higher in invasive cancer (Figure 5A). The gene discussed is SHE; the disease is in situ carcinoma.